MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 1.580
- +0.050+3.27%
Close Dec 20 16:00 ET
- 1.540
- -0.040-2.53%
Post 20:01 ET
240.31MMarket Cap-9.88P/E (TTM)
1.620High1.460Low2.57MVolume1.480Open1.530Pre Close4.05MTurnover2.24%Turnover RatioLossP/E (Static)152.09MShares3.93052wk High-6.01P/B181.70MFloat Cap1.04052wk Low--Dividend TTM115.00MShs Float830.000Historical High--Div YieldTTM10.46%Amplitude0.500Historical Low1.574Avg Price1Lot Size
Heron Therapeutics News
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(5.84%),Robert Atchinson(5.84%), etc.
Heron Therapeutics | 8-K: Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
Heron Therapeutics | 10-Q: Q3 2024 Earnings Report
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Heron Therapeutics | 8-K: Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
Heron Therapeutics | 10-Q: Q2 2024 Earnings Report
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | 8-K: Current report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.